NR2C2AP

NR2C2AP (TRA16) is a nuclear protein that functions as a selective modulator of testicular orphan nuclear receptor signaling within the NR2C subfamily (PMID:12486131, PMID:23129017). It acts as a co-repressor of TR4 (NR2C2), binding the receptor through both its DNA-binding and ligand-binding domains and suppressing TR4-mediated transactivation by decreasing TR4 occupancy at its response elements (PMID:12486131). This repressor activity is receptor-selective, with only slight effects on androgen, glucocorticoid, and progesterone receptors (PMID:12486131). NR2C2AP also physically engages the related receptor TR2 (NR2C1), where it blocks TR2's inhibitory effect on ERβ-mediated transcription and thereby enhances ERβ transactivation (PMID:23129017). Beyond these nuclear-receptor interactions, no broader pathway placement or structural mechanism has been characterized in the available corpus.

1. 2002 High

   Establishing how NR2C2AP controls TR4 signaling answered whether a dedicated repressor restrains this orphan nuclear receptor and by what molecular route.

   Evidence Mammalian two-hybrid, reciprocal co-immunoprecipitation, EMSA, and reporter transactivation assays mapping interaction to TR4's DNA-binding and ligand-binding domains

   PMID:12486131

   Open questions at the time

   • No identification of additional co-repressor complex partners recruited by NR2C2AP
   • Direct target genes of TR4 modulated in vivo not defined
   • No structural detail of the TR4-NR2C2AP interface
2. 2002 Medium

   Comparing multiple nuclear receptors established that NR2C2AP repression is receptor-selective rather than a general transcriptional dampener.

   Evidence Reporter gene transactivation assays comparing TR4 against androgen, glucocorticoid, and progesterone receptors

   PMID:12486131

   Open questions at the time

   • Selectivity tested only against a limited panel of steroid receptors
   • Basis of selectivity at the sequence/domain level not resolved
3. 2002 Medium

   Localizing NR2C2AP placed it in the nucleus, consistent with a role in transcriptional regulation.

   Evidence Subcellular localization assay reported within the functional characterization study

   PMID:12486131

   Open questions at the time

   • Imaging methodology not detailed
   • Whether localization changes upon receptor binding not addressed
4. 2012 Medium

   Extending the receptor repertoire showed NR2C2AP also acts on TR2 to indirectly potentiate ERβ activity, broadening its role beyond TR4 repression.

   Evidence Mammalian two-hybrid, co-immunoprecipitation, immunocytofluorescence, and reporter assays in Cos-1 cells

   PMID:23129017

   Open questions at the time

   • Single-lab evidence without reciprocal validation in a second cell system
   • Domain mapping of the TR2 interaction not performed
   • Physiological ERβ targets affected not identified
5. 2012 Low

   Overexpression linked NR2C2AP to a cellular proliferation phenotype, hinting at a downstream consequence of its receptor modulation.

   Evidence Cell proliferation assay after NR2C2AP introduction into Cos-1 cells

   PMID:23129017

   Open questions at the time

   • Single method, single cell line without loss-of-function confirmation
   • Causal link between proliferation and receptor modulation not established
   • No in vivo or disease-relevant validation

• It remains unknown whether NR2C2AP nucleates a defined co-repressor complex and what endogenous gene programs it controls through TR4, TR2, and ERβ.
• No identified co-repressor complex subunits
• No genome-wide target gene mapping
• No structural model of receptor binding